Yongchang Zhang

机构：Qinghai University, Central South University, Sun Yat-sen University, National Medical Products Administration, National Energy Research Center, Hunan Cancer Hospital, Sun Yat-sen University Cancer Center, University of South China

发表论文 245 篇 · 总被引 3236 次 · h-index 28

代表论文

• Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 60)
• Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration (2025 · JCO Oncology Practice · 被引 5)
• Overall survival according to time‐of‐day of immunochemotherapy for extensive‐stage small cell lung cancer (2025 · Cancer · 被引 3)
• Expert Consensus on the Diagnosis and Treatment of Malignant Mesothelioma of the Tunica Vaginalis Testis (2025 · iMetaMed · 被引 3)
• Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC (2025 · iScience · 被引 3)
• Clinical Outcomes of Patients With Advanced ALK-Rearranged Lung Squamous Cell Carcinoma Treated With ALK Tyrosine Kinase Inhibitors (2025 · Clinical Lung Cancer · 被引 3)